PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
---|---|---|---|---|---|---|---|
24803091 | HLA (HLA) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
and we analyzed the feasibility and outcome of hematopoietic stem cell transplantation (hsct) in 13 children (median age 5.9 years) with hemoglobinopathies after the co- infusion of cord blood (cb) and bone marrow (bm) from the same human leucocyte antigen (hla) identical sibling donor. | |||||||
24803091 | HLA (HLA) | hemoglobinopathies | NA | NA | NA | unclassified | |
and we analyzed the feasibility and outcome of hematopoietic stem cell transplantation (hsct) in 13 children (median age 5.9 years) with hemoglobinopathies after the co- infusion of cord blood (cb) and bone marrow (bm) from the same human leucocyte antigen (hla) identical sibling donor. | |||||||
24803091 | HLA IDENTICAL (HLA-IDENTICAL) | hemoglobinopathies | NA | NA | NA | unclassified | |
co-transplantation of cb and bm from hla-identical sibling donors appears to be a feasible and effective strategy to further optimize outcomes of hsct for hemoglobinopathies. | |||||||
25023628 | HLA MATCHED (HLA-MATCHED) | hematopoietic stem cell transplantation | NA | NA | NA | positive | |
functional donor nk cells expressing kirs for non-self class i mhc ligands contribute to a positive outcome after allogeneic hematopoietic stem cell transplantation (allohsct) by targeting hla-matched recipient leukemic cells. | |||||||
25040134 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | hematopoietic stem cell transplantation | NA | NA | NA | positive+negation | |
genetic matching for loci in the human leukocyte antigen (hla) region between a donor and a patient in hematopoietic stem cell transplantation (hsct) is critical to outcome; however, methods for hla genotyping of donors in unrelated stem cell registries often yield results with allelic and phase ambiguity and/or do not query all clinically relevant loci. | |||||||
25179788 | HLA MATCHED (HLA-MATCHED) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
hla-haploidentical hematopoietic stem cell transplantation (hsct) is suitable for patients lacking related or unrelated hla-matched donors. | |||||||
25198529 | MHC (MHC) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
tcr+cd4-cd8- t cells in antigen-specific mhc class i-restricted t-cell responses after allogeneic hematopoietic stem cell transplantation. | |||||||
25220758 | HLA-DRB1*15 | hematopoietic stem cell transplantation | Taiwanese | NA | NA | unclassified | |
hla-drb1*15:02:11, a variant of hla-drb1*15:02:01, revealed in a taiwanese patient awaiting hematopoietic stem cell transplantation. | |||||||
25220758 | HLA-DRB1*15 | hematopoietic stem cell transplantation | Taiwanese | NA | NA | unclassified | |
hla-drb1*15:02:11, a variant of hla-drb1*15:02:01, revealed in a taiwanese patient awaiting hematopoietic stem cell transplantation. | |||||||
25352173 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | hematopoietic stem cell transplantation | Chilean | NA | NA | unclassified | |
the studies reported here were performed for support of a collaborative hematopoietic stem cell transplantation program at luis calvo mackenna hospital for which st. jude children's research hospital provided human leukocyte antigen (hla) typing. |
Copyright 2024